BPTH — Bio Path Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $0.62m
- $1.05m
Annual cashflow statement for Bio Path Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.9 | -10.4 | -13.9 | -16.1 | -9.89 |
| Depreciation | |||||
| Non-Cash Items | 0.656 | 0.906 | 0.941 | 1.1 | -1.41 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.806 | -0.459 | -2.26 | 3.36 | 0.678 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -11 | -9.92 | -15.1 | -11.5 | -10.6 |
| Capital Expenditures | — | -0.07 | -0.021 | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.07 | -0.021 | — | — |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 4.29 | 20 | 1.73 | 2.2 | 10.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.67 | 10 | -13.4 | -9.33 | 0.121 |